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BACKGROUND: Anabolic-androgenic steroid compounds are one of the most widely abused drugs by athletes and muscle builders with 
the goal of improving performance/ability, appearance, or muscle mass. In addition, these steroids are widely used in the treatment of male 
infertility and subfertility. However, increasing concern has been shown that these compounds may not only offer unappreciable benefits to 
infertile and subfertile males, but might have deleterious effects on both human and animal physiology and sperm quality. There is a dearth of 
knowledge on the structural and quantitative changes of the testis secondary to this group of compounds. 
Objective: The present study was carried out to evaluate the effects of mesterolone (proviron), an anabolic-androgenic steroid, on some of 
the histomorphometric and stereological parameters of the seminiferous tubules in Sprague-Dawley rat.
Materials and Methods: Two groups of 10 adult male rats were used. The treated group was given 0.06 mg/kg body weight/day of 
mesterolone by gavage for six weeks while the control group received equal volume of 0.9% normal saline per day. Five µm of uniformly 
random serial sections of the processed testicular tissues were analyzed using un-biased stereological and histomorphometric studies. 
Results: The results showed that the percentage mean volume density of both the tubular lumen and epithelial height increased by 35% (p< 
0.05) and decreased by 50% (p<0.05), respectively compared to the control. mesterolone also caused a significant decline in sperm 
concentration.
Conclusion: Mesterolone produces epithelial hypoplasia in the testis post continuous management.
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INTRODUCTION
Increasing concern has been expressed with regards to the 
role of anabolic-androgenic steroid (AAS) compounds, which are 
one of the most widely abused drugs by athletes and muscle 
builders with the goal of improving performance/ability, 
appearance, or muscle mass. Mesterolone (1alpha-methyl-5alpha-
androstan-17beta-ol-3-one) is a synthetic AAS with reported 
abuses in human sports (1).
Synthetic (exogenous) androgen has been used in the 
treatment of male infertility through its generally accepted direct 
stimulatory or rebound effect on the reproductive axis. This is 
based on the principle that the process of spermatogenesis is 
androgen and follicle-stimulating hormone-dependent (2). The 
mechanism of action of androgens is either through direct 
stimulatory increase in intratesticular testosterone level which 
enhances spermatogenesis or influence on sperm transport and 
maturation through its effect on epididymis, ductus deferens and 
seminal vesicles (3). Androgens with rebound effect (e.g. 
testosterone enanthate) suppress spermatogenesis and secretion of 
gonadotrophins (follicle-stimulating hormone and luteinizing 
hormone) which are usually relieved when treatment with the 
drugs is discontinued (3).
The abuse of AAS, especially dihydrotestosterone (DHT) by 
athletes is on the increase because it has been observed that DHT 
helps to prevent estrogenic side effects such as fat gain and water 
retention associated with substance abuse (4). 
 AAS has been shown to prevent the estrogen-dependent
augmentation of the progesterone cytosol (PRc) receptors in 
 human breast cancer cells. In addition, DHT and its metabolites 
demonstrate a very high degree of inhibition of estrogen in human 
breast cancer cells (4). Androgens are capable of inhibiting both 
 the estrogenic induction and the ongoing stimulation of PRc 
 receptor synthesis, but have no apparent effect upon basal 
concentrations of this receptor (4). 
 Androgenic and anabolic effects of AAS originate from 
 activation of the androgenic receptors. The distinction between 
 these biological effects depends on the organs and target tissues.  
 DHT is responsible for the androgeniceffect. This steroid is more 
 potent than testosterone because of increased affinity to the 
 androgen receptor. It is formed from conversion of testosterone 
 by the 5á-reductase enzyme. Activity of this enzyme is 
 important in testicles, skin, prostate, intestines, brain, bones, and 
 adipose tissues. Therefore, androgenic effects of AAS 
 predominate in these organs. Anabolic steroids are essentially 
synthetic derivatives of testosterone, modified to enhance its 
anabolic actions (promotion of protein synthesis and muscle 
 growth). Anabolic effects concern organs such as muscles, bones,
the heart and kidneys. These organs possess little 5á-
 reductase activity and thus AAS compounds induce protein 
synthesis, muscle fibre development, erythropoiesis, and variable 
 effects on bone growth (5, 6). In addition, anabolic steroids 
 displace glucocorticoids fromglucocorticoid receptors and inhibit 
 muscle protein catabolism, leading overall to an anabolic or 
muscle-building effect. Other mechanisms of direct and indirect 
anabolic effects include increases in the creatine phosphokinase 
activity in skeletal muscle, and increases in both circulating 
insulin-like growth factor- (IGF)1 (7) as well as up-regulation of 
IGF-1 receptors (8). AAS has been found to contribute to 
androgen action on the testis with some degree of support for 
residual spermatogenesis (9).
Because, mesterolone might have a beneficial effect by 
keeping estrogen in check, it is open to abuse by athletes. 
However, the conflicting outcomes of its use in the clinical 
settings in the treatment of male infertility have necessitated the 
need for this study.  




T h e  p r o v i r o n  ( a  p r o d u c t  o f  S c h e r i n g  A G  
Germany/Allemagne, LOT # WEA6WX, manufactured date 
(MFD): 06, 2004, expirydate (EXP): 06, 2009) used for this study 
was bought from a pharmaceutical shop in Agege, Lagos, Nigeria. 
Each oral tablet contains 25 mg of mesterolone with 20 tablets in a 
bottle.
Preparation of drug
Proviron was dissolved in 100 ml of distilled water to make up 
to 0.06 mg/kg body weight/day, based on the physiological 
calculation for a 70 kg man. 
Animal
Twenty mature and healthy adult male Sprague-Dawley rats 
weighing 120 to 200 g were procured from the Animal House of 
Lagos State University, College of Medicine, Ikeja and housed in a 
well ventilated wire-wooden cages in the departmental Animal 
House. They were maintained under controlled light schedule (12 
ohours Light: 12 hours Dark) at room temperature (28 C) and with 
constant humidity (40-50%). The animals acclimatized for a 
period of 14 days before the commencement of treatment. During 
this period, they were fed with standard rat chows/pellets supplied 
by Pfizer Nigeria Ltd and water ad-libitum. Ear tag was used for the 
individual identification of the entire group animals.
Experimental procedure
The rats were randomly divided into two groups of ten rats 
each. The treated groups received 0.06 mg/kg body weight /day of 
proviron solution via gastric gavage (oro-gastric intubation) daily, 
while the control group received equal volume of 0.9% (w/v) 
normal saline daily for a period of 6 weeks. 
All procedures involving animals in this study conformed to 
the guiding principles for research involving animals as 
recommended by the Declaration of Helsinki and the Guiding 
Principles in the Care and Use of Animals (10) and approved by the 
Departmental Committee on ethics and research.
Animal sacrifice  
The rats were anaesthetized after an overnight fasting using 
the procedure described in our previous study (11). Weekly 
weighing of the animals was carried out all through the 
experimental period.
Organ Harvest 
The testes were initially dissected out whole via midline 
abdominal incision, cleared of fats and blotted dry. Their weights 
were measured on a sensitive digital balance while the volume was 
measured by water displacement using a 10 ml measuring cylinder. 
Later, the sizes (length and width) were recorded by use of a sliding 
gauge (d=0.1) before eventually fixed in freshly prepared 10% 
formol saline solution as earlier described (11). The two testes of 
each rat were measured and the average value obtained for each of 
the parameters was regarded as one observation.
Tissue processing for Light Microscopy
Serial paraffin sections of 5 µm were obtained from fixed 
processed testicular tissue blocks and stained with Haematoxylin 
and Eosin (H & E) stains as prepared and previously described in 
our earlier studies (9,11).
Morphometric parameters
The following morphometric parameters: testicular volume 
and weight; diameter; and cross-sectional area of the seminiferous 
tubules, were determined.
The diameter (D) of seminiferous tubules with profiles that 
were round or nearly round for each animal was estimated. A 
mean, D, was taken as the average of two diameters, D1 and D2 
(D1 is the short axis while, D2 is the long axis).  D1 and D2 were 
considered only when ratio of D1: D2 or D1/D2>0.85 (Form 
factor). 
The cross-sectional areas (A ) of the seminiferous tubules was C
determined from the formula 
2A =ðD /4, (where ð is equivalent to 3.142 and D = the C
mean diameter of the seminiferous tubules).
Determination of stereological parameters
Serial transverse sections of 5 µm of the H & E-stained 
specimens prepared were subjected to un-biased stereological 
techniques modified from previous report (12). Each image of the 
seminiferous tubules at a magnification of 400x was projected and 
drawn on a 16-point grid, completely counted in 6 different fields 
to make a total of 96 point-test grid for each of the 5 sections/rat 
from each group. Manual point/intercept counting methods 
consist of a counting grid made up of a series of crosses in a regular 
and uniform square array. The density of crosses was such that one 
2cross represented an area of 4 cm  on the counting grid. The total 
number of crosses (circled or otherwise) falling on each structure 
of interest was counted for each section and summated. Using this 
procedure, the volume density of the stroma, epithelia lining and 
tubular lumen of seminal vesicles were estimated as previously 
described by Weibel and Gomez (13). The percentage volume 
density was determined by multiplying the volume density by 100.
Statistical analysis        
Data were expressed in Mean±SD (standard deviation). All 
the data were inputted into, and analyzed by SPSS (Statistical 
Package for Social Sciences). Comparison between groups was 
done using the student’s t-test and non-parametric Mann-Whitney 
U test. Statistical significance was considered at p<0.05. 
RESULTS
Evidence of significant (p<0.05) weight gain was observed in 
all the animals. Both the raw testicular weight and relative 
testicular weight decreased significantly (p<0.05) in the proviron-
treated group as compared to the control (table 1). 
The mean caudal epididymal sperm concentration of the 
control group was significantly (p<0.05) higher than the proviron-
6treated group (80±17.6 vs. 58±24.5 x10 ) (table 1).
The percentage mean volume density of the tubular lumen 
increased by 35%, while that of the epithelial height deceased by 
50% (p<0.05) in the proviron-treated rats when compared to the 
control (table 2).  The mean diameter of the seminiferous tubules 
of proviron-treated group (305.3±4.9 µm) was significantly 
(p<0.05) different from that of the control (295.5±5.0 µm) (table 
2).
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Table 1: Effects of proviron (mesterolone) on sperm concentration, testicular and body weights of 
Sprague-Dawley rats
Treatment Pre-experimental Final body Testicular Testicular body Sperm 
6Group (n=10) body weight  (g) weight (g) weight (g) weight (wt/100g count (x10 )
body weight)
Control 127.3 ± 6.40 184.4 ±12.6 1.24 ± 0.01 0.67 ± 0.01 80 ± 17.6 
Proviron 159.4 ± 5.16 185.2 ± 12.8 0.89 ± 0.09* 0.55 ± 0.01* 58 ± 24.5*
Values are mean±SD 
*: Significantly different from the control group at p<0.05
Table 2: Effects of proviron (mesterolone) on volume fraction of testicular tissue profile and diameter of seminiferous 
tubule of Sprague-Dawley rats
Treatment Group Interstitium Surface Epithelia Tubular Lumen Seminiferous 
Tubular Diameter (µm)
   
Control 0.14 ± 0.06 0.82 ± 0.06 0.04 ± 0.01 305.3 ± 4.9
Proviron 0.31 ± 0.06* 0.4 ± 0.08* 0.19 ± 0.04* 295.5 ± 5.0*
Values are mean±SEM; n = 10 in each group.
*: Significantly different from the control group at <0.05.
DISCUSSION
We now know that combination of a well characterized 
animal model with stereological techniques always allow for 
proper quantitative study of any hormonal impact on male 
reproductive system (14). Application of stereological and 
morphometric techniques as new approaches in modern medicine 
and biomedical sciences/researches are on the increase in recent 
years (15).  
This present study had used matured adult male rats because 
morphometric study by light microscopy is best performed when 
the organ has reasonably developed to a sizable dimension (15). In 
addition, rat appears to be a suitable animal model for studying the 
roles of the androgenic hormones within the male reproductive 
system in that it operates on a two-way androgen model of sexual 
differentiation (DHT and testosterone), unlike, in mouse model 
which is dependent on testosterone action alone for the 
differentiation of the male urogenital tract (16).
In this study, we have utilized stereological technique and 
histomorphometric analysis to compare the effects of oral 
proviron intake with normal saline on the testis of adult male 
Sprague-Dawley rats. Proviron was found to reduce the testicular 
weight as compared to control. This is contrary to the effect of 
proviron which is thought to enhance weight gain (4). These 
differential changes in weight of testes were well correlated with 
the seminiferous tubular profile of the testes for each group of 
animals. 
Since, proviron is a known androgen that binds to the 
androgen receptor in the testis, one expects that it would stimulate 
spermatogenesis because DHT strongly binds to the receptor than 
testosterone and also have more appreciable effect on it. This is 
however, not our experience in this study, as proviron-treated rats 
had lower sperm concentration than the controls. The reason for 
this is not clear. The marginal value recorded for the mean volume 
fraction of the surface epithelium of the seminiferous tubules of 
the treated group might be an indication of some residual 
spermatogenesis seen in the testis.
Studies have shown that sections of tissues are usually 
compressed by 83% of their original dimension, thereby 
necessitating the need of a correction factor. However, volume 
densities are not affected by this compression (12) and hence 
appeared more suitable for the present study.  
The increase of 35% in percentage mean volume density of the 
seminiferous tubular lumen and 50% decrease in epithelial height 
showed that proviron has reduced epithelial height and activity, 
thus it is not surprising that spermatogenic activity and sperm 
output were reduced by 50% compared to the control in this present 
study. 
Degenerative features such as luminal dilatation (up to 35%) 
and reduction in the epithelial height amongst others are factors 
that probably culminated in testicular atrophy in the proviron-
treated rats. These findings are in consonance with observations 
from some earlier work (19, 20), but at variance with a study that 
found that 17 á-propylmesterolone, a synthetic 5 alpha-
reduced steroid had no influence on testes weights (21) 
There is no doubt that a complex hormonal interplay exists at 
the level of the hypothalamic- testicular axis, which may partly be 
responsible for our findings. Further studies are, however, 
necessary to elucidate the exact mechanism of proviron-induced 
seminiferous atrophy.
CONCLUSION
Proviron induces atrophy of the seminiferous tubules of adult 
Sprague-Dawley rats and disrupts spermatogenesis. The role of 
this steroid in the management of male infertility will need to be 
reviewed based on the results of present study. In fact, proviron 
could probably have a role to play as hormonal contraceptive in the 
light of present findings. 
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